Adherence With Iron Sprinkles Among High-Risk Infants

Completed · Phase 3

Conditions studied: Anemia, Iron Deficiency

In brief

Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.

Key facts

Study ID

NCT00136266

Run by

Centers for Disease Control and Prevention

People needed

128

Starts

2005-03-01

Expected to finish

2005-12-01

Last updated by the study team

2016-02-03

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy infants
• Age 5-7 months
• Presenting for 6 months well-child care
• Caregiver speaks English or Spanish

You may not qualify if…

• Pre-existing medical conditions with potential relation to iron deficiency or anemia (e.g., hemoglobinopathies, gastrointestinal disorders resulting in malabsorption, chronic renal disease, gestational age at birth of less than 36 weeks, and HIV infection)
• Inability to speak English or Spanish
• Use of vitamin or iron supplements in the previous three months

Where it is running

• Whittier Street Health Center — Boston, Massachusetts, United States
• Boston Medical Center Pediatric Primary Care Clinic — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.